β‐Catenin mediates tumor‐induced immunosuppression by inhibiting cross‐priming of CD8+ T cells

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Leukocyte Biology

• Publication date

  2014-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1189/jlb.0613330PMID 24023259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tolerogenic dendritic cells

  2016cited by this paper
• Radiation-driven lipid accumulation and dendritic cell dysfunction in cancer

  2015cited by this paper
• β-Catenin promotes the differentiation of epidermal Langerhans dendritic cells.

  2013cited by this paper
• Cancer immunotherapy via dendritic cells

  2012cited by this paper
• [Dendritic cells for cancer immunotherapy].

  2012cited by this paper
• Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells.

  2012cited by this paper
• Targeting Dendritic Cells in vivo for Cancer Therapy

  2012cited by this paper
• Dendritic cell‐targeted protein vaccines: a novel approach to induce T‐cell immunity

  2012cited by this paper
• Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells.

  2012cited by this paper
• Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

  2012cited by this paper
• Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.

  2012cited by this paper
• Cancer immunotherapy comes of age

  2011cited by this paper
• Natural innate and adaptive immunity to cancer.

  2011cited by this paper
• Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer

  2011cited by this paper
• Harnessing dendritic cells in cancer.

  2011cited by this paper
• TGF-β Suppresses β-Catenin-Dependent Tolerogenic Activation Program in Dendritic Cells

  2011cited by this paper
• Dendritic cell control of tolerogenic responses

  2011cited by this paper
• Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?

  2011cited by this paper
• FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.

  2011influential reference
• A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity.

  2011cited by this paper
• Generation of tolerogenic dendritic cells via the E-cadherin/β-catenin-signaling pathway

  2010cited by this paper
• Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly

  2010cited by this paper
• CD8+ T Cell Priming by Dendritic Cell Vaccines Requires Antigen Transfer to Endogenous Antigen Presenting Cells

  2010cited by this paper
• Activation of β-Catenin in Dendritic Cells Regulates Immunity Versus Tolerance in the Intestine

  2010cited by this paper
• Cross-priming in health and disease

  2010cited by this paper
• Dendritic cells as therapeutic agents against cancer.

  2010cited by this paper
• Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes.

  2010cited by this paper
• Dendritic cells in cancer immunotherapy

  2010cited by this paper
• Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth.

  2010cited by this paper
• Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways.

  2010cited by this paper
• Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells.

  2009cited by this paper
• Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

  2009cited by this paper
• Activated Wnt/ß-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model

  2009cited by this paper
• TGFβ secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect

  2008cited by this paper
• Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice.

  2008cited by this paper
• Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory.

  2008cited by this paper
• Cancer immunotherapy by dendritic cells.

  2008influential reference
• Taking dendritic cells into medicine

  2007cited by this paper
• Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation.

  2007influential reference
• Notch–RBP-J signaling controls the homeostasis of CD8− dendritic cells in the spleen

  2007cited by this paper
• Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination

  2005cited by this paper
• Functional Interaction Between ß-Catenin and FOXO in Oxidative Stress Signaling

  2005cited by this paper
• Wnt signalling in stem cells and cancer

  2005cited by this paper
• Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4+CD25+ regulatory T cell proliferation

  2005cited by this paper
• Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice.

  2005cited by this paper
• Cutting Edge: Generation of Splenic CD8+ and CD8− Dendritic Cell Equivalents in Fms-Like Tyrosine Kinase 3 Ligand Bone Marrow Cultures1

  2005cited by this paper
• In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination

  2004influential reference
• Some interfaces of dendritic cell biology

  2003cited by this paper
• Tolerogenic dendritic cells.

  2003cited by this paper
• Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance

  2002cited by this paper
• Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo

  2001cited by this paper
• Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development.

  2001cited by this paper
• Intestinal polyposis in mice with a dominant stable mutation of the β‐catenin gene

  1999cited by this paper

• Rewiring Dendritic Cell Immunity: The β-Catenin–TIM-3 Axis as a Target to Improve DC Cancer Vaccines

  2026influential citation
• Balancing Immunity: GSK-3’s Divergent Roles in Dendritic Cell-Mediated T-Cell Priming and Memory Responses

  2025cites this paper
• GSK-3β in Dendritic Cells Exerts Opposite Functions in Regulating Cross-Priming and Memory CD8 T Cell Responses Independent of β-Catenin

  2024influential citation
• Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer

  2024cites this paper
• β-Catenin in Dendritic Cells Negatively Regulates CD8 T Cell Immune Responses through the Immune Checkpoint Molecule Tim-3

  2024cites this paper
• CD84 as a therapeutic target for breaking immune tolerance in triple-negative breast cancer.

  2024cites this paper
• Highlighting function of Wnt signalling in urological cancers: Molecular interactions, therapeutic strategies, and (nano)strategies

  2024cites this paper
• Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer

  2023cites this paper
• Development and applications of mRNA treatment based on lipid nanoparticles.

  2023cites this paper
• Dendritic Cell-Based Vaccines Against Cancer: Challenges, Advances and Future Opportunities

  2022cites this paper
• Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression

  2022cites this paper
• Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade.

  2022cites this paper
• Biological and clinical review of IORT-induced wound fluid in breast cancer patients

  2022cites this paper
• The Hallmarks of Cancer as Ecologically Driven Phenotypes

  2021cites this paper
• Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment

  2021cites this paper
• N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target

  2021cites this paper
• BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer

  2021cites this paper
• Lactate-Dependent Regulation of Immune Responses by Dendritic Cells and Macrophages

  2021cites this paper
• Altered glycolysis results in drug-resistant in clinical tumor therapy.

  2021cites this paper
• T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A+CD141+ cDC1 and CD14+ antigen-presenting cell recruitment

  2021cites this paper
• Wnt Inhibition Sensitizes PD-L1 Blockade Therapy by Overcoming Bone Marrow-Derived Myofibroblasts-Mediated Immune Resistance in Tumors

  2021cites this paper
• Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated β-Catenin Activation Compared with Squamous Cell Carcinoma

  2020cites this paper
• Wnt signalling pathway in bladder cancer.

  2020cites this paper
• Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy

  2020cites this paper
• Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes

  2020cites this paper
• Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints

  2020cites this paper
• Therapeutic normal IgG intravenous immunoglobulin activates Wnt-β-catenin pathway in dendritic cells

  2020cites this paper
• Breast Tumor Microenvironment: Emerging target of therapeutic phytochemicals.

  2020cites this paper
• Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity

  2020cites this paper
• Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma

  2019cites this paper
• Tackling immunotherapy resistance: Developing rational combinations of immunotherapy and targeted drugs

  2019cites this paper
• Immunometabolism: A new target for improving cancer immunotherapy.

  2019cites this paper
• Wnt Signaling in Cancer Metabolism and Immunity

  2019cites this paper
• Hepatocellular carcinoma: Mechanisms of progression and immunotherapy

  2019cites this paper
• Macrophages as a Source and Recipient of Wnt Signals

  2019cites this paper
• Dendritic cells in cancer immunology and immunotherapy

  2019cites this paper
• β‐Catenin stabilization in NOD dendritic cells increases IL‐12 production and subsequent induction of IFN‐γ‐producing T cells

  2019cites this paper
• Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics

  2019cites this paper
• CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer.

  2019cites this paper
• Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion

  2019cites this paper
• New Therapies and Immunological Findings in Melanoma and Other Skin Cancers

  2019cites this paper
• Mechanisms of Resistance to Immune Checkpoint Antibodies.

  2018cites this paper
• Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy.

  2018cites this paper
• Human endogenous retrovirus-K (HML-2): a comprehensive review

  2018cites this paper
• Wnt3a Neutralization Enhances T-cell Responses through Indirect Mechanisms and Restrains Tumor Growth

  2018cites this paper
• Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer

  2018cites this paper
• Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment

  2018cites this paper
• Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma

  2017cites this paper
• Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors

  2017cites this paper
• Interaction of molecular alterations with immune response in melanoma

  2017cites this paper
• Tumor-infiltrating lymphocytes are associated with β-catenin overexpression in breast cancer

  2017cites this paper
• Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression.

  2017cites this paper
• Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer

  2016cites this paper
• Deletion of LRP5 and LRP6 in dendritic cells enhances antitumor immunity

  2016cites this paper
• Wnt/β-catenin signaling in melanoma: Preclinical rationale and novel therapeutic insights.

  2016cites this paper
• Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy.

  2016cites this paper
• Dendritic cells as gatekeepers of tolerance

  2016cites this paper
• β-catenin promotes regulatory T-cell responses in tumors by inducing vitamin A metabolism in dendritic cells.

  2015cites this paper
• Tumors induce immune tolerance through activation of β-catenin/TCF4 signaling in dendritic cells: A novel therapeutic target for cancer immunotherapy

  2015cites this paper
• β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8+ T cells through regulation of IL-10

  2015cites this paper
• Dendritic Cell-Specific Deletion of β-Catenin Results in Fewer Regulatory T-Cells without Exacerbating Autoimmune Collagen-Induced Arthritis

  2015cites this paper
• β-catenin in dendritic cells plays both positive and negative roles in regulating anti-tumor CD8 T cell responses

  2015cites this paper
• Canonical Wnt Signaling in Dendritic Cells Regulates Th1/Th17 Responses and Suppresses Autoimmune Neuroinflammation

  2015cites this paper
• Wnt signaling in dendritic cells: its role in regulation of immunity and tolerance.

  2015cites this paper
• FOXO3–NF-κB RelA Protein Complexes Reduce Proinflammatory Cell Signaling and Function

  2015cites this paper
• Dendritic Cell-Targeted Vaccines

  2014cites this paper
• EXOSOMES FROM CT26 CELLS PROMOTE TUMOR PROGRESSION BY SUBVERTING MACROPHAGE FROM M1 TO M2 MEDIATED PARTIALLY BY INTERLEUKIN-4

  2014cites this paper
• β-catenin-mediated inhibition of cross-priming

  2013cites this paper